Science Explorer Back to mapMap
Discussion
Company · Heidelberg · Germany

Novaliq (Germany)

novaliq.comROR OpenAlex
Research works
21
▼ 35% vs 2018-21
Citations
325
15.2 per fractional work
Top-10% rate
24.8%
all institutions 10.0%
Open access
52%
world 40%
International
73%
world 18%
Novaliq (Germany)

Not ranked overall: Novaliq (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Novaliq (Germany) work in?

In all years, 70% of research at Novaliq (Germany) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (70%), Biochemistry, Genetics and Molecular Biology (11%), Pharmacology, Toxicology and Pharmaceutics (8%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 69.5% of its workMedicine: 15 fractional works · 69.5% of its workPublic Health, Environmental and Occupational Health: 4 fractional works · 20.5% of its workOphthalmology: 3 fractional works · 12.0% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 11.2% of its workSurgery: 1 fractional works · 6.9% of its workPhysiology: 1 fractional works · 4.1% of its workEpidemiology: 0 fractional works · 2.1% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.5% of its workDermatology: 0 fractional works · 1.5% of its workTransplantation: 0 fractional works · 1.3% of its workImmunology and Allergy: 0 fractional works · 1.2% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.9% of its workGastroenterology: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.6% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workNephrology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workOncology: 0 fractional works · 0.3% of its workLife Sciences: 5 fractional works · 23.9% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 10.5% of its workMolecular Biology: 1 fractional works · 6.4% of its workCell Biology: 0 fractional works · 1.7% of its workGenetics: 0 fractional works · 1.4% of its workBiotechnology: 0 fractional works · 0.8% of its workCancer Research: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 8.1% of its workPharmaceutical Science: 2 fractional works · 8.1% of its workImmunology and Microbiology: 1 fractional works · 2.7% of its workImmunology: 1 fractional works · 2.7% of its workNeuroscience: 0 fractional works · 2.0% of its workBehavioral Neuroscience: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.8% of its workSensory Systems: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workFood Science: 0 fractional works · 0.6% of its workPhysical Sciences: 1 fractional works · 6.6% of its workEngineering: 1 fractional works · 3.0% of its workBiomedical Engineering: 0 fractional works · 2.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 2.0% of its workMaterials Chemistry: 0 fractional works · 1.2% of its workBiomaterials: 0 fractional works · 0.8% of its workChemistry: 0 fractional works · 1.0% of its workSpectroscopy: 0 fractional works · 1.0% of its workEnvironmental Science: 0 fractional works · 0.3% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workInstrumentation: 0 fractional works · 0.3% of its workALL ITS WORKNovaliq (Germany)21fractional works, all years
Life Sciences24%Physical Sciences7%Health Sciences70%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 11 fields, with their numbers
    1. Medicine1569.5%
    1. Biochemistry, Genetics and Molecular Biology210.5%
    2. Pharmacology, Toxicology and Pharmaceutics28.1%
    3. Immunology and Microbiology12.7%
    4. Neuroscience02.0%
    5. Agricultural and Biological Sciences00.6%
    1. Engineering13.0%
    2. Materials Science02.0%
    3. Chemistry01.0%
    4. Environmental Science00.3%
    5. Physics and Astronomy00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.31× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.85× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 29.34× its world share, 0 worksPharmacology, Toxico…Engineering: 0.20× its world share, 0 worksEngineeringPhysics and Astronomy: 0.66× its world share, 0 worksPhysics and AstronomyMedicine: 4.12× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 29.3×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics29.34×0 works
  2. Medicine4.12×4 works
  3. Biochemistry, Genetics and Molecular Biology0.85×0 works
  4. Physics and Astronomy0.66×0 works
  5. Agricultural and Biological Sciences0.31×0 works
  6. Engineering0.20×0 works

Who are the top researchers at Novaliq (Germany)?

Ranked on the quality score, Sonja Krösser and Bastian Theisinger lead among researchers whose main affiliation is Novaliq (Germany).

  1. 1 Sonja Krösser Germany · #382,137 worldwide 1.1k citations · 35 works
  2. 2 Bastian Theisinger Germany · #5,044,407 worldwide 343 citations · 25 works
All ranked researchers at Novaliq (Germany)

What are the most cited papers from Novaliq (Germany)?

The most cited paper from Novaliq (Germany) is "NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction" (Joseph Tauber et al., 2022), with 100 citations. Next come "A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease" (86) and "Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease" (76).

Most cited papers
#PaperReleasedCitations
1 NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction Joseph Tauber et al. · Ophthalmology Open access 24 Dec 2022 100
2 A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease David Wirta, Gail L. Torkildsen, Helen R. Moreira et al. · Ophthalmology Open access 28 Jan 2019 86
3 Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease Esen K. Akpek, David Wirta, Johnathon Downing et al. · JAMA Ophthalmology Open access 6 Apr 2023 76
4 Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study Philipp Steven, Dieter Scherer, Sonja Krösser et al. · PubMed Central Open access Oct 2015 72
5 Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs Priyanka Agarwal, Dieter Scherer, Bernhard Günther et al. · International Journal of Pharmaceutics 12 Jan 2018 71
All 71 most cited papers, with filters and sorting

Which keywords describe research at Novaliq (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Dry Eye Disease, Ocular Surface, Oxidative Stress, Wound Healing, Corneal Regeneration, Tissue Engineering and Nanoparticles.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Epidemiology5▲ 6.2×8 topics
  2. Dry Eye Disease4▲ 570×1 topic
  3. Ocular Surface4▲ 570×1 topic
  4. Oxidative Stress3▲ 6.7×10 topics
  5. Inflammation2▲ 4.0×9 topics
  6. Wound Healing2▲ 38×2 topics
  7. Corneal Regeneration2▲ 277×1 topic
  8. Nanoparticles2▲ 6.5×4 topics
  9. Tissue Engineering2▲ 15×1 topic
  10. Intravitreal Injection2▲ 103×2 topics
  11. Chitosan1▲ 108×1 topic
  12. Mucosal1▲ 215×1 topic
  13. Antibiotic Resistance1▲ 13×2 topics
  14. Diabetes Mellitus1▲ 23×2 topics
  15. Intraocular Pressure1▲ 49×2 topics
  16. Neuroprotection1▲ 14×6 topics
  17. Endophthalmitis1▲ 119×1 topic
  18. Keratitis1▲ 263×1 topic

Which research topics does Novaliq (Germany) publish most on?

By volume in 2022-now: Ocular Surface and Contact Lens, Corneal Surgery and Treatments, Advanced Drug Delivery Systems and Ocular Infections and Treatments.

Ocular Surface and Conta…1Ocular Surface and Contact Lens: 1 fractional worksCorneal Surgery and Trea…1Corneal Surgery and Treatments: 1 fractional worksAdvanced Drug Delivery Systems: 0 fractional worksOcular Infections and Treatments: 0 fractional worksRetinal Diseases and Tre…0Retinal Diseases and Treatments: 0 fractional worksGlaucoma and retinal disorders: 0 fractional worksProtein purification and stability: 0 fractional worksConnexins and lens biology: 0 fractional worksCorneal surgery and disorders: 0 fractional worksOcular Diseases and Behçet’s Syndrome: 0 fractional works
Public Health, Environmental and Occupational HealthRadiology, Nuclear Medicine and ImagingPharmaceutical ScienceOphthalmology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 1 works
  2. 2 Corneal Surgery and Treatments Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  4. 4 Ocular Infections and Treatments Ophthalmology 0 works
  5. 5 Retinal Diseases and Treatments Ophthalmology 0 works
  6. 6 Glaucoma and retinal disorders Ophthalmology 0 works
  7. 7 Protein purification and stability Molecular Biology 0 works
  8. 8 Connexins and lens biology Molecular Biology 0 works
  9. 9 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Ocular Diseases and Behçet’s Syndrome Ophthalmology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.7%not open48.3%

World: 40% of research is openly available.

with international co-authors72.8%domestic only27.2%

World: 18% is written across borders.

How has Novaliq (Germany)'s research output changed?

Output in 2022-2025 was 35% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Novaliq (Germany) as a percentage of every work published that year, 0.000026% in 2024.

still counting0.000025%0.000050%0.000075%Novaliq (Germany)0.000016% in 202520102020

Fractional works of Novaliq (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Heidelberg

All research institutions in Heidelberg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Novaliq (Germany). Posts are plain text and can be reported.